Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction

Urology

Volumn 69, Issue 4, 2007, Pages 795-799

  Wiesner, Christoph ^a,c   Bonfil, R Daniel ^a,b   Dong, Zhong ^a   Yamamoto, Hamilto ^a   Nabha, Sanaa M ^a   Meng, Hong ^a   Saliganan, Allen ^a   Sabbota, Aaron ^a   Cher, Michael L ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE GRAFT; CANCER CELL; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL INTERACTION; CELL LYSATE; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SCID MOUSE; TISSUE CULTURE; XENOGRAFT; ZYMOGRAPHY;

ANIMALS; BONE AND BONES; CELLS, CULTURED; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, SCID; PROSTATIC NEOPLASMS;

EID: 34147184846     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.093     Document Type: Article

References (29)

1. Strongin A.Y. Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev 25 (2006) 87-98
2. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10 (2000) 415-433
3. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25 (2006) 9-34
4. Acuff H.B., Carter K.J., Fingleton B., et al. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 66 (2006) 259-266
5. DeClerck Y.A. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36 (2000) 1258-1268
6. Jodele S., Blavier L., Yoon J.M., et al. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25 (2006) 35-43
7. Somerville R.P., Oblander S.A., and Apte S.S. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4 (2003) 216-226
8. Dong Z., Bonfil R.D., Chinni S., et al. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am J Pathol 166 (2005) 1173-1186
9. Bonfil R.D., Sabbota A., Nabha S., et al. Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. Int J Cancer 118 (2006) 2721-2726
10. Kaighn M.E., Narayan K.S., Ohnuki Y., et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17 (1979) 16-23
11. Wu T.T., Sikes R.A., Cui Q., et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77 (1998) 887-894
12. Yamamoto H., Bonfil R.D., Wiesner C., et al. Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging. Prostate 67 (2006) 107-114
13. Nemeth J.A., Harb J.F., Barroso Jr. U., et al. Severe combined immunodeficient-human model of human prostate cancer metastasis to human bone. Cancer Res 59 (1999) 1987-1993
14. Lange P.H., and Vessella R.L. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metastasis Rev 17 (1998) 331-336
15. Carlin B.I., and Andriole G.L. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 88 (2000) 2989-2994
16. Catalona W.J. Management of cancer of the prostate. N Engl J Med 331 (1994) 996-1004
17. Petrylak D.P., Tangen C.M., Hussain M.H., et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351 (2004) 1513-1520
18. Tannock I.F., de Wit R., Berry W.R., et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351 (2004) 1502-1512
19. Stearns M.E., Fudge K., Garcia F., et al. IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Invas Metast 17 (1997) 62-74
20. Festuccia C., Giunciuglio D., Guerra F., et al. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Oncol Res 11 (1999) 17-31
21. Kanoh Y., Akahoshi T., Ohara T., et al. Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer. Anticancer Res 22 (2002) 1813-1817
22. Corey E., Brown L.G., Quinn J.E., et al. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res 9 (2003) 295-306
23. Nemeth J.A., Yousif R., Herzog M., et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst 94 (2002) 17-25
24. Sehgal G., Hua J., Bernhard E.J., et al. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol 152 (1998) 591-596
25. Corey E., Quinn J.E., Bladou F., et al. Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. Prostate 52 (2002) 20-33
26. Lee Y.P., Schwarz E.M., Davies M., et al. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res 62 (2002) 5564-5570
27. Yonou H., Yokose T., Kamijo T., et al. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 61 (2001) 2177-2182
28. Nabha S.M., Bonfil R.D., Yamamoto H.A., et al. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis. Clin Exp Metastasis 23 (2006) 335-344
29. Masson V., de la Ballina L.R., Munaut C., et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 19 (2005) 234-236